{"url_path":"/sec/celz/8-k/2026-07-02/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/1187953/0001477932-26-004165-index.html","accession_number":"0001477932-26-004165","cik":"0001187953","ticker":"CELZ","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1187953/0001477932-26-004165-index.html","primary_entity_key":"0001187953","primary_entity_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC."},"word_count":52,"has_tables":true,"body_markdown":"**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**\n\n \n\nOn July 1, 2026, the Compensation Committee of the Company’s Board of Directors approved the payment of a bonus to Timothy Warbington, the Company’s Chief Executive Officer, in the amount of $100,000."}